Quantitative interpretation of PF4/heparin‐EIA optical densities in predicting platelet‐activating VITT antibodies
Linda Schönborn, Thomas Thiele, Max Esefeld, Khalil El Debuch, Jan Wesche, Seydou Nourou Seck, Lars Kaderali, Martina Wolff, Theodore E. Warkentin, Andreas Greinacher
Topics & Concepts
Platelet factor 4AntibodyImmunologyPlateletImmunoassayPlatelet activationSerologyChemistryMedicineHeparin-Induced Thrombocytopenia and ThrombosisPlatelet Disorders and TreatmentsSARS-CoV-2 and COVID-19 Research